|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||
| Depreciation | |||||
| Unrealized loss gain on marketable securities | |||||
| Change in right-of-use asset and operating lease liability | |||||
| Amortization of note issuance costs | |||||
| Deferred income taxes | |||||
| Employee restricted stock forfeiture | |||||
| Stock-based compensation | |||||
| Change in operating assets and liabilities: | |||||
| Investment fee income receivable | |||||
| Interest income receivable | |||||
| Prepaid expenses | |||||
| Other accounts receivable | |||||
| Other assets | |||||
| Accrued liabilities and accounts payable | |||||
| Income taxes payable | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property and equipment | |||||
| Payments related to management contracts | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of notes, net of underwriting discount | |||||
| Payment of issuance costs on notes | |||||
| Repurchase of vested employee restricted stock for tax withholding | |||||
| Proceeds from shares issued pursuant to the 2021 Dividend Reinvestment and Stock Repurchase Plan | |||||
| Two Thousand Eighteen Dividend Reinvestment and Stock Purchase Plan | |||||
| Two Thousand Twenty One Dividend Reinvestment and Stock Purchase Plan | |||||
| Two Thousand Twenty Four Dividend Reinvestment and Stock Purchase Plan | |||||
| Dividend payments | |||||
| Net cash used in financing activities | |||||
| Cash and cash equivalents at the beginning of the period | |||||
| Cash and cash equivalents at the end of the period | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of the period | |||||
| Cash and cash equivalents at the end of the period | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid for income taxes | |||||
| Cash paid for interest | |||||
| Dividend investment issued in shares | |||||
| Payments related to management contracts in accrued liabilities | |||||
Loading...